AI assistant
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2017
Jun 30, 2017
31920_dirs_2017-06-30_ad6c4234-f015-445c-bf95-dbd8ed812435.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2017-06-28
Reporting Person: VAN ASSCHE BENOIT (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-28 | Stock Option (right to buy) | $10.51 | A | 30000 | Acquired | 2022-06-28 | ADSs (30000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (right to buy) | $14.54 | 2018-06-24 | ADSs (46000) | 46000 | Direct |
| Warrants (right to buy) | $21.67 | 2019-06-26 | ADSs (54026) | 54026 | Direct |
| Warrants (right to buy) | $13.59 | 2020-08-10 | ADSs (54026) | 54026 | Direct |
Footnotes
F1: Warrants were granted 06/24/2014 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 46,000 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)10.94 per ADS.
F2: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F3: Warrants were granted 06/26/2015 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS.
F4: Warrants were granted 08/10/2016 but are not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants will become exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 4 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro) 12.16 per ADS. Warrants as to all 54,026 ADSs vest on 08/10/2017.
F5: Options become exercisable as to all 30,000 ADSs on the first anniversary of the 06/28/2017 grant date.